Year archive

IMMUNIC, INC. — 2025 filings

All 75 regulatory filings released by IMMUNIC, INC. (IMUX) in 2025, sourced directly from the official regulator.

75 Filings

2025 Period

2025 filings (75)

Filing	Released	Lang
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December Regulatory Filings	2025-11-26	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-14	English
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update Earnings Release Q3 2025	2025-11-13	English
Regulatory Filings 2025 Regulatory Filings	2025-11-13	English
10-Q Interim / Quarterly Report Q3 2025	2025-11-13	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-07	English
Immunic to Participate in Industry and Investor Conferences in November Regulatory Filings	2025-10-29	English
Immunic to Participate in Scientific and Investor Conferences in October Regulatory Filings	2025-10-01	English
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis Regulatory Filings	2025-09-25	English
Regulatory Filings 2025 Regulatory Filings	2025-09-25	English
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis Regulatory Filings	2025-09-09	English
Immunic to Participate in Investor and Scientific Conferences in September Regulatory Filings	2025-09-04	English
Registration Form 2025 Registration Form	2025-08-27	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-12	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-08	English
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update Earnings Release Q2 2025	2025-08-07	English
10-Q Interim / Quarterly Report Q2 2025	2025-08-07	English
Regulatory Filings 2025 Regulatory Filings	2025-08-07	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-07-31	English
FORM 4 Director's Dealing	2025-07-18	English
Director's Dealing 2025 Director's Dealing	2025-07-18	English
Director's Dealing 2025 Director's Dealing	2025-07-18	English
Director's Dealing 2025 Director's Dealing	2025-07-18	English
Director's Dealing 2025 Director's Dealing	2025-07-18	English
Regulatory Filings 2025 Regulatory Filings	2025-07-11	English
Regulatory Filings 2025 Regulatory Filings	2025-06-27	English
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Earnings Release FY 2024	2025-06-24	English
Director's Dealing 2025 Director's Dealing	2025-06-20	English
FORM 4 Director's Dealing	2025-06-20	English
Director's Dealing 2025 Director's Dealing	2025-06-20	English
Director's Dealing 2025 Director's Dealing	2025-06-20	English
Director's Dealing 2025 Director's Dealing	2025-06-20	English
Director's Dealing 2025 Director's Dealing	2025-06-16	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
FORM 4 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-09	English
Director's Dealing 2025 Director's Dealing	2025-06-06	English
Director's Dealing 2025 Director's Dealing	2025-06-05	English
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS Earnings Release FY 2024	2025-06-05	English
FORM 4 Director's Dealing	2025-06-04	English
Regulatory Filings 2025 Regulatory Filings	2025-06-04	English
Director's Dealing 2025 Director's Dealing	2025-06-04	English
Immunic to Participate in Investor, Scientific and Industry Conferences in June Regulatory Filings	2025-06-02	English
FORM 8-K Regulatory Filings	2025-05-30	English
Prospectus 2025 Prospectus	2025-05-30	English
Prospectus 2025 Prospectus	2025-05-28	English
Regulatory Filings 2025 Regulatory Filings	2025-05-28	English
10-Q Interim / Quarterly Report Q1 2025	2025-05-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-15	English
Regulatory Filings 2025 Regulatory Filings	2025-04-30	English
Regulatory Filings 2025 Regulatory Filings	2025-04-22	English
Proxy Solicitation & Information Statement 2025 Proxy Solicitation & Information Statement	2025-04-22	English
Prospectus 2025 Prospectus	2025-04-09	English
Regulatory Filings 2025 Regulatory Filings	2025-04-09	English
10-K Annual Report FY 2024	2025-03-31	English
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023 Audit Report / Information FY 2023	2025-03-05	German
Regulatory Filings 2025 Regulatory Filings	2025-02-20	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-12	English
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023 Audit Report / Information FY 2023	2025-02-04	German
Major Shareholding Notification 2025 Major Shareholding Notification	2025-01-30	English
Regulatory Filings 2025 Regulatory Filings	2025-01-13	English

Filings by year

2026 29 filings
2025 75 filings
2024 73 filings
2023 39 filings
2022 66 filings
2021 48 filings
2020 59 filings
2019 78 filings
2018 52 filings
2017 59 filings
2016 46 filings
2015 46 filings
2014 72 filings
2013 22 filings
2012 4 filings
2011 4 filings
2010 5 filings
2009 3 filings
2007 1 filing
2006 1 filing
2005 2 filings
2004 2 filings